These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36424174)

  • 21. Platelet Membrane-Coated r-SAK Improves Thrombolytic Efficacy by Targeting Thrombus.
    Hua R; Li M; Lin Q; Dong M; Gong X; Lin Z; Li Y; Li C; Wu T; Tan C; Zhang W; Wang Q; Wu T; Zhou X; Yang F; Li C
    ACS Appl Mater Interfaces; 2024 May; 16(17):21438-21449. PubMed ID: 38626407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.
    Kajimoto Y; Ohta T; Kuroiwa T
    Neurosurgery; 1997 Mar; 40(3):572-7. PubMed ID: 9055298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
    Chen HA; Ma YH; Hsu TY; Chen JP
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation of thrombus-targeted urokinase liposomes and its thrombolytic effect in model rats].
    Wang XT; Li S; Zhang XB; Hou XP
    Yao Xue Xue Bao; 2003 Mar; 38(3):231-5. PubMed ID: 12830724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bionanoengineered 2D monoelemental selenene for piezothrombolysis.
    Hu H; Xia L; Wang J; Huang X; Zhao Q; Song X; Hu L; Ren S; Lu C; Ren Y; Qian X; Feng W; Wang Z; Chen Y
    Biomaterials; 2024 Mar; 305():122468. PubMed ID: 38219628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM
    Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet activation by fibrinolytic agents: a potential mechanism for resistance to thrombolysis and reocclusion after successful thrombolysis.
    Leopold JA; Loscalzo J
    Coron Artery Dis; 1995 Dec; 6(12):923-9. PubMed ID: 8723013
    [No Abstract]   [Full Text] [Related]  

  • 29. RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy.
    Xu Z; Huang J; Zhang T; Xu W; Liao X; Wang Y; Wang G
    J Mater Sci Mater Med; 2023 Apr; 34(4):18. PubMed ID: 37043085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.
    Boulaftali Y; Lamrani L; Rouzaud MC; Loyau S; Jandrot-Perrus M; Bouton MC; Ho-Tin-Noé B
    Thromb Haemost; 2012 May; 107(5):962-71. PubMed ID: 22552380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy.
    Wang S; Wang R; Meng N; Guo H; Wu S; Wang X; Li J; Wang H; Jiang K; Xie C; Liu Y; Wang H; Lu W
    J Control Release; 2020 Dec; 328():78-86. PubMed ID: 32853731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined thrombolytic therapy for atrial thrombus in a preterm infant.
    Mondì V; Di Paolo A; Fabiano A; Cicchese M; De Merulis G; Giannini C; Del Principe D
    Minerva Pediatr; 2011 Apr; 63(2):115-8. PubMed ID: 21487375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chemical conjugation of recombinant single-chain urokinase-type plasminogen activator with monoclonal antiplatelet antibodies on platelet aggregation and on plasma clot lysis in vitro and in vivo.
    Dewerchin M; Lijnen HR; Stassen JM; De Cock F; Quertermous T; Ginsberg MH; Plow EF; Collen D
    Blood; 1991 Aug; 78(4):1005-18. PubMed ID: 1831057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis.
    Collen D; Stassen JM; Blaber M; Winkler M; Verstraete M
    Thromb Haemost; 1984 Aug; 52(1):27-30. PubMed ID: 6541817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets.
    Wang X; Palasubramaniam J; Gkanatsas Y; Hohmann JD; Westein E; Kanojia R; Alt K; Huang D; Jia F; Ahrens I; Medcalf RL; Peter K; Hagemeyer CE
    Circ Res; 2014 Mar; 114(7):1083-93. PubMed ID: 24508759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computer simulation of systemic circulation and clot lysis dynamics during thrombolytic therapy that accounts for inner clot transport and reaction.
    Anand S; Diamond SL
    Circulation; 1996 Aug; 94(4):763-74. PubMed ID: 8772700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel chimaeric derivative of saruplase, rscu-PA-40 kDA/Hir, binds to thrombin and exerts thrombus-specific fibrinolysis in arterial and venous thrombosis in dogs.
    Schneider J; Hauser R; Hennies HH; Korioth J; Steffens G; Wnendt S
    Thromb Haemost; 1997 Mar; 77(3):535-9. PubMed ID: 9066007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities.
    Chen H; Mo W; Su H; Zhang Y; Song H
    BMC Mol Biol; 2007 Oct; 8():88. PubMed ID: 17919340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A thrombolytic therapy using diagnostic ultrasound combined with RGDS-targeted microbubbles and urokinase in a rabbit model.
    Guan L; Wang C; Yan X; Liu L; Li Y; Mu Y
    Sci Rep; 2020 Jul; 10(1):12511. PubMed ID: 32719362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urokinase-coated chitosan nanoparticles for thrombolytic therapy: preparation and pharmacodynamics in vivo.
    Jin HJ; Zhang H; Sun ML; Zhang BG; Zhang JW
    J Thromb Thrombolysis; 2013 Nov; 36(4):458-68. PubMed ID: 23728739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.